694 related articles for article (PubMed ID: 31283845)
1. Mesothelioma: Scientific clues for prevention, diagnosis, and therapy.
Carbone M; Adusumilli PS; Alexander HR; Baas P; Bardelli F; Bononi A; Bueno R; Felley-Bosco E; Galateau-Salle F; Jablons D; Mansfield AS; Minaai M; de Perrot M; Pesavento P; Rusch V; Severson DT; Taioli E; Tsao A; Woodard G; Yang H; Zauderer MG; Pass HI
CA Cancer J Clin; 2019 Sep; 69(5):402-429. PubMed ID: 31283845
[TBL] [Abstract][Full Text] [Related]
2. Validation of the diagnosis of mesothelioma and BAP1 protein expression in a cohort of asbestos textile workers from Northern Italy.
Boffetta P; Righi L; Ciocan C; Pelucchi C; La Vecchia C; Romano C; Papotti M; Pira E
Ann Oncol; 2018 Feb; 29(2):484-489. PubMed ID: 29206890
[TBL] [Abstract][Full Text] [Related]
3. Germline BAP1 Mutational Landscape of Asbestos-Exposed Malignant Mesothelioma Patients with Family History of Cancer.
Ohar JA; Cheung M; Talarchek J; Howard SE; Howard TD; Hesdorffer M; Peng H; Rauscher FJ; Testa JR
Cancer Res; 2016 Jan; 76(2):206-15. PubMed ID: 26719535
[TBL] [Abstract][Full Text] [Related]
4. Consensus Report of the 2015 Weinman International Conference on Mesothelioma.
Carbone M; Kanodia S; Chao A; Miller A; Wali A; Weissman D; Adjei A; Baumann F; Boffetta P; Buck B; de Perrot M; Dogan AU; Gavett S; Gualtieri A; Hassan R; Hesdorffer M; Hirsch FR; Larson D; Mao W; Masten S; Pass HI; Peto J; Pira E; Steele I; Tsao A; Woodard GA; Yang H; Malik S
J Thorac Oncol; 2016 Aug; 11(8):1246-1262. PubMed ID: 27453164
[TBL] [Abstract][Full Text] [Related]
5. Germline BAP1 mutations predispose to malignant mesothelioma.
Testa JR; Cheung M; Pei J; Below JE; Tan Y; Sementino E; Cox NJ; Dogan AU; Pass HI; Trusa S; Hesdorffer M; Nasu M; Powers A; Rivera Z; Comertpay S; Tanji M; Gaudino G; Yang H; Carbone M
Nat Genet; 2011 Aug; 43(10):1022-5. PubMed ID: 21874000
[TBL] [Abstract][Full Text] [Related]
6. Minimal asbestos exposure in germline BAP1 heterozygous mice is associated with deregulated inflammatory response and increased risk of mesothelioma.
Napolitano A; Pellegrini L; Dey A; Larson D; Tanji M; Flores EG; Kendrick B; Lapid D; Powers A; Kanodia S; Pastorino S; Pass HI; Dixit V; Yang H; Carbone M
Oncogene; 2016 Apr; 35(15):1996-2002. PubMed ID: 26119930
[TBL] [Abstract][Full Text] [Related]
7. Germline mutations in DNA repair genes predispose asbestos-exposed patients to malignant pleural mesothelioma.
Betti M; Casalone E; Ferrante D; Aspesi A; Morleo G; Biasi A; Sculco M; Mancuso G; Guarrera S; Righi L; Grosso F; Libener R; Pavesi M; Mariani N; Casadio C; Boldorini R; Mirabelli D; Pasini B; Magnani C; Matullo G; Dianzani I
Cancer Lett; 2017 Oct; 405():38-45. PubMed ID: 28687356
[TBL] [Abstract][Full Text] [Related]
8. Preventive and therapeutic opportunities: targeting BAP1 and/or HMGB1 pathways to diminish the burden of mesothelioma.
Carbone M; Minaai M; Takinishi Y; Pagano I; Yang H
J Transl Med; 2023 Oct; 21(1):749. PubMed ID: 37880686
[TBL] [Abstract][Full Text] [Related]
9. Sensitivity to asbestos is increased in patients with mesothelioma and pathogenic germline variants in BAP1 or other DNA repair genes.
Betti M; Aspesi A; Ferrante D; Sculco M; Righi L; Mirabelli D; Napoli F; Rondón-Lagos M; Casalone E; Vignolo Lutati F; Ogliara P; Bironzo P; Gironi CL; Savoia P; Maffè A; Ungari S; Grosso F; Libener R; Boldorini R; Valiante M; Pasini B; Matullo G; Scagliotti G; Magnani C; Dianzani I
Genes Chromosomes Cancer; 2018 Nov; 57(11):573-583. PubMed ID: 30338612
[TBL] [Abstract][Full Text] [Related]
10. Peripheral Blood DNA Methylation as Potential Biomarker of Malignant Pleural Mesothelioma in Asbestos-Exposed Subjects.
Guarrera S; Viberti C; Cugliari G; Allione A; Casalone E; Betti M; Ferrante D; Aspesi A; Casadio C; Grosso F; Libener R; Piccolini E; Mirabelli D; Dianzani I; Magnani C; Matullo G
J Thorac Oncol; 2019 Mar; 14(3):527-539. PubMed ID: 30408567
[TBL] [Abstract][Full Text] [Related]
11. Current approach to malignant mesothelioma of the pleura.
Aisner J
Chest; 1995 Jun; 107(6 Suppl):332S-344S. PubMed ID: 7781415
[TBL] [Abstract][Full Text] [Related]
12. Benign and malignant pleural mesothelioma.
Antman KH; Corson JM
Clin Chest Med; 1985 Mar; 6(1):127-40. PubMed ID: 3891207
[TBL] [Abstract][Full Text] [Related]
13. [Asbestos and malignant pleural mesothelioma: molecular, cellular and physiopathological aspects].
Mohr S; Keith G; Rihn B
Bull Cancer; 2005 Nov; 92(11):959-76. PubMed ID: 16316830
[TBL] [Abstract][Full Text] [Related]
14. Asbestos. 'A cruel and nasty disease'.
Millar B
Nurs Times; 2000 May 25-31; 96(21):32-3. PubMed ID: 11962950
[No Abstract] [Full Text] [Related]
15. The use of surgery in mesothelioma.
Lim JY; Wolf AS; Flores RM
Lancet Respir Med; 2013 May; 1(3):184-6. PubMed ID: 24429116
[No Abstract] [Full Text] [Related]
16. Peritoneal mesothelioma: the site of origin matters.
Kindler HL
Am Soc Clin Oncol Educ Book; 2013; ():182-8. PubMed ID: 23714495
[TBL] [Abstract][Full Text] [Related]
17. Germline mutation of Bap1 accelerates development of asbestos-induced malignant mesothelioma.
Xu J; Kadariya Y; Cheung M; Pei J; Talarchek J; Sementino E; Tan Y; Menges CW; Cai KQ; Litwin S; Peng H; Karar J; Rauscher FJ; Testa JR
Cancer Res; 2014 Aug; 74(16):4388-97. PubMed ID: 24928783
[TBL] [Abstract][Full Text] [Related]
18. An asbestos-exposed family with multiple cases of pleural malignant mesothelioma without inheritance of a predisposing BAP1 mutation.
Cheung M; Kadariya Y; Pei J; Talarchek J; Facciolo F; Visca P; Righi L; Cozzi I; Testa JR; Ascoli V
Cancer Genet; 2015 Oct; 208(10):502-7. PubMed ID: 26364129
[TBL] [Abstract][Full Text] [Related]
19. [Malignant pleural mesothelioma].
Sritharan SS; Frandsen JL; Omland Ø; Bruun JM
Ugeskr Laeger; 2018 Apr; 180(15):. PubMed ID: 29690982
[TBL] [Abstract][Full Text] [Related]
20. [Twenty-one patients of malignant pleural mesothelioma in the Senshu district].
Hasegawa Y; Nagayasu F; Moriyama A; Uejima H; Yoon HE
Nihon Kokyuki Gakkai Zasshi; 2009 May; 47(5):347-54. PubMed ID: 19514493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
